Key Figures

 

  • Over 21,000 employees worldwide

  • 94 million patients treated worldwide with Servier products and generics
  • 5 Major R&D areas: cardiovascular, diabetes, cancer, neuropsychiatry and immune-inflammatory
  • Present in 148 countries over 5 continents
  • 16 International Centres of Clinical Development